Abstract
Mice without the gene for tenascin-C, a multifunctional extracellular matrix protein expressed in many important biological events, including wound healing, did not show any phenotype. However, it is now obvious that the phenotype of deletion of one gene frequently depends on the genetic background. Therefore, we have newly generated tenascin-C knockout mice (KO) by backcrossing original KO into three congenic lines: C57BL/6N, BALB/cA, and GRS/A (GR). And we investigated the disease course of reversible kidney injury, Habu-snake venom-induced proliferative glomerulonephritis. In all strains, the disease was more severe in KO, but the severity varied with the strain. The KO-GR showed irreversibility; all treated KO-GR died by the 4th month due to renal failure. The diseased KO-GR showed abnormal regenerative reactions, including reduced proliferation of mesangial cells, key players in glomerulonephritis, and reduced production of some kinds of cytokines and matrices, leading to poor formation of granulation tissue. In culture, the mesangial cells from the KO-GR had the same potential for proliferation and response to cytokines as controls, but interestingly, to achieve this potential, they required contact with tenascin-C. These reactions were blocked by an anti-tenascin monoclonal antibody. The results of the present study, the first report showing the most dramatic phenotype so far discovered, have strongly suggested the importance of tenascin-C in the resolution of the renal inflammation and that of the genetic background on which the KO was developed.
MeSH Terms
Animals
Cell Count
Cell Division
Cells, Cultured
Collagen/metabolism
Crotalid Venoms/toxicity
Cytokines/metabolism
DNA Primers/chemistry
Fibronectins/metabolism
Glomerular Mesangium/drug effects,pathology,physiology
Glomerulonephritis, Membranoproliferative/chemically induced,metabolism,pathology,physiopathology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Knockout
Regeneration
Tenascin/physiology
Trimeresurus
Wound Healing/physiology
Chemicals
Crotalid Venoms
Cytokines
DNA Primers
Fibronectins
Tenascin
Collagen
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Nakao N
Renal Division, Internal Medicine, GenGen do-Kimitu Hospital, Chiba, Japan.
Hiraiwa N
Yoshiki A
Ike F
Kusakabe M
References (21)
21 references, click to expand
-
Induction of tenascin in healing wounds.
J Cell Biol. 1988 Dec;107(6 Pt 2):2757-67
PMID: 2462568
-
The glomerular mesangial cell: an expanding role for a specialized pericyte.
FASEB J. 1987 Oct;1(4):272-81
PMID: 3308611
-
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.
J Clin Invest. 1991 Mar;87(3):847-58
PMID: 1671868
-
In situ hybridization with non-radioactive digoxigenin-11-UTP-labeled cRNA probes: localization of developmentally regulated mouse tenascin mRNAs.
Int J Dev Biol. 1991 Mar;35(1):25-32
PMID: 1714291
-
Induction of irreversible glomerulosclerosis in the rat by repeated injections of a monoclonal anti-Thy-1.1 antibody.
Nephron. 1992;60(1):92-9
PMID: 1738421
-
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor.
J Exp Med. 1992 May 1;175(5):1413-6
PMID: 1569407
-
Mice develop normally without tenascin.
Genes Dev. 1992 Oct;6(10):1821-31
PMID: 1383086
-
Tenascin: a modulator of cell growth.
Eur J Biochem. 1992 Nov 1;209(3):1041-51
PMID: 1385122
-
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.
Nature. 1992 Nov 26;360(6402):361-4
PMID: 1280332
-
Gene knockouts of c-src, transforming growth factor beta 1, and tenascin suggest superfluous, nonfunctional expression of proteins.
J Cell Biol. 1993 Mar;120(5):1079-81
PMID: 7679670
-
Induction of tenascin in cancer cells by interactions with embryonic mesenchyme mediated by a diffusible factor.
J Cell Sci. 1993 Feb;104 ( Pt 2):289-96
PMID: 7685035
-
Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;63(5):307-16
PMID: 7685961
-
Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions.
Curr Opin Cell Biol. 1993 Oct;5(5):869-76
PMID: 7694605
-
Tenascin knockout mice: barrels, boundary molecules, and glial scars.
J Neurosci. 1995 Mar;15(3 Pt 1):1971-83
PMID: 7534342
-
Abnormal behavior and neurotransmissions of tenascin gene knockout mouse.
Biochem Biophys Res Commun. 1996 Apr 5;221(1):151-6
PMID: 8660327
-
Skin wounds and severed nerves heal normally in mice lacking tenascin-C.
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6594-9
PMID: 8692862
-
Tenascin: growth and adhesion modulation--extracellular matrix degrading function: an in vitro study.
Eur J Cancer B Oral Oncol. 1996 Mar;32B(2):106-13
PMID: 8736172
-
Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.
Mol Biol Cell. 1996 Jun;7(6):883-92
PMID: 8816995
-
Mesangiolysis.
Kidney Int. 1983 Jul;24(1):1-9
PMID: 6353041
-
Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis.
Cell. 1986 Oct 10;47(1):131-9
PMID: 2428505
-
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.
Cell. 1991 Feb 22;64(4):841-8
PMID: 1847668